Tranexamic acid

Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent. It was first patented in 1957 and received its initial US approval in 1986. It is grouped under the following drug class(es): Amino Acids. Its therapeutic use is listed as dermatologicals and hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Amcha, Lysteda and Rikavarin. Its PubChem CID is 5526.

CAS No 1197-18-8
Molecular Formula C8H15NO2
Molecular Weight 157.21 g/mol
Synonyms trans-4-(Aminomethyl)cyclohexanecarboxylic acid

Frequently Asked Questions